Behavioral Symptoms: Clinical Trials

4 trials for Behavioral Symptoms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 enrolling by invitation. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Enrolling by invitation 4

Follow Behavioral Symptoms: new trials by email Literature Review of Behavioral Symptoms trials Research Report on Behavioral Symptoms

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis
ML-007C-MA - Psychosis Associated With Alzheimer's Disease
Phase 2Enrolling by invitationMapLight Therapeutics2102026-03-252026-08-07
Bright Light Therapy for Depressed Geriatric Inpatients
Bright light therapy, dim red light - Unipolar Depression
Phase 2Enrolling by invitationMedical University of South Carolina202025-11-142026-04-16
An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)
SPT-300 - Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress
Phase 2Enrolling by invitationSeaport Therapeutics3602025-09-022026-10-06
Ketamine Effects on Learning In Eating Disorders
Ketamine infusion - Anorexia Nervosa, Atypical Anorexia Nervosa
Phase 2Enrolling by invitationAmanda Downey, MD202025-06-052026-10-13

Narrower conditions

Depression (3)  ·  Anxiety Disorders (2)  ·  Depressive Disorder (2)  ·  Alzheimer Disease (1)  ·  Anorexia (1)  ·  Anorexia Nervosa (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Delusions (1)  ·  Dementia (1)  ·  Depressive Disorder, Major (1)  ·  Feeding and Eating Disorders (1)  ·  Hallucinations (1)  ·  Mental Disorders (1)  ·  Mood Disorders (1)

Broader conditions

Behavior (4)  ·  Mental Disorders (3)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Mood Disorders (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)  ·  Perceptual Disorders (1)  ·  Signs and Symptoms, Digestive (1)  ·  Trauma and Stressor Related Disorders (1)

Interventions

Phototherapy (1)  ·  Ultraviolet Therapy (1)

Sponsors

Amanda Downey, MD (1)  ·  MapLight Therapeutics (1)  ·  Medical University of South Carolina (1)  ·  Seaport Therapeutics (1)

Countries

United States (4)  ·  Bulgaria (2)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Poland (1)  ·  Slovakia (1)

Top investigators

Amanda E. Downey, MD (1)  ·  David Walling, Ph.D. (1)  ·  Rindy Fernandes, DO (1)

NIH funding

2025 (2), KL2TR001870 (1), R25DA020537 (1)